These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2568646)

  • 1. Neuroleptic-induced persistent "open mouth".
    Priebe S; Stahl HP; Deymann R
    Pharmacopsychiatry; 1989 May; 22(3):126-7. PubMed ID: 2568646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic-induced tardive dyskinesia.
    Jenner P; Marsden CD
    Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroleptic-induced movement disorders: historical perspectives].
    Wolf MA; Yassa R; Llorca PM
    Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive tourettism after exposure to neuroleptic therapy.
    Bharucha KJ; Sethi KD
    Mov Disord; 1995 Nov; 10(6):791-3. PubMed ID: 8749999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables.
    Ezrin-Waters C; Seeman MV; Seeman P
    J Clin Psychiatry; 1981 Jan; 42(1):16-22. PubMed ID: 6109715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pisa syndrome].
    García C
    Nervenarzt; 1992 Jul; 63(7):434-9. PubMed ID: 1354332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia: managing a common neuroleptic side effect.
    Jeste DV; Krull AJ; Kilbourn K
    Geriatrics; 1990 Dec; 45(12):49-54. PubMed ID: 1979304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dyskinesia presenting as gastrointestinal disorder.
    Goldberg RJ; Morris PL; Lidofsky S
    J Clin Psychiatry; 1990 Jun; 51(6):253-4. PubMed ID: 1971823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Occurrence of tardive extrapyramidal symptoms in schizophrenic patients undergoing prolonged neuroleptic treatment].
    Rybakowski J; Jaracz J; Lis B; Milewska G; Lezańska M
    Psychiatr Pol; 1979; 13(5):479-85. PubMed ID: 42096
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroleptic drugs: how to reduce the risk of tardive dyskinesia.
    DeVeaugh-Geiss J
    Geriatrics; 1979 Jul; 34(7):59-61, 66. PubMed ID: 36330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tardive dyskinesia.
    Granacher RP
    Am Fam Physician; 1978 Apr; 17(4):163-8. PubMed ID: 25576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with dimethylaminoethanol (deanol) in neuroleptic induced tardive dyskinesia].
    Kocher R; Hobi V; Linder M; Studer K
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):103-9. PubMed ID: 6106283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composition and effects of commonly used neuroleptics.
    Culshaw F
    Nurs Times; 1994 Sep 21-27; 90(38):38-40. PubMed ID: 7971331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Movement disorders induced by neuroleptic therapy].
    Almeida R; Santos MV
    Acta Med Port; 1993 Jun; 6(6):239-44. PubMed ID: 8103618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
    Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
    Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic measures in tardive dyskinesia].
    Tegeler J; Wöller W
    Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent tardive dyskinesia in randomly assigned neuroleptic reduction, neuroleptic nonreduction, and no-neuroleptic history groups: preliminary results.
    Kalachnik JE; Harder SR; Kidd-Nielsen P; Errickson E; Doebler M; Sprague RL
    Psychopharmacol Bull; 1984; 20(1):27-32. PubMed ID: 6144132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.